The PSMA prostate recurrence study is a multisenter prospective trial where the overall aim is to evaluate the diagnostic accuracy of 18F/68Ga-PSMA PET for detection of disease in patients with biochemical recurrence. In this preliminary analysis, we have compared the clinical imaging report of PET/CT/mpMRI to a separate evaluation of mpMRI where the radiologist was blinded to the PET results. Of 94 patients included so far, recurrent disease and/or distant metastasis was detected in 44 % (median PSA 0.4 ng/ml), according to the imaging protocol while the detection rate was 17 % for the mpMRI study scoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords